Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Oncotarget
|
July 23, 2016
Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies
Xiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
ACS Chemical Biology
|
February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma
Hong Wu, Wenchao Wang, Feiyang Liu, et al.
Leukemia
|
May 26, 2016
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML
H Wu, A Wang, Z Qi, et al.
Oncotarget
|
April 16, 2016
Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignances
Xiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Phosphorylation-inducing chimera rewires oncogenic kinase to trigger apoptosis
Manuel L Merz, Veronika M Shoba, Rajaiah Pergu, et al.
Nature Chemical Biology
|
October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3
Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
ACS Central Science
|
April 27, 2026
Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis
Manuel L Merz, Veronika M Shoba, Rajaiah Pergu, et al.
Scientific Reports
|
March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Nathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Leukemia
|
July 14, 2015
Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
H Wu, C Hu, A Wang, et al.
Leukemia
|
May 6, 2026
Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
H Wu, C Hu, A Wang, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Oncotarget
|
July 23, 2016
Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies
Xiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
ACS Chemical Biology
|
February 22, 2014
Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma
Hong Wu, Wenchao Wang, Feiyang Liu, et al.
Leukemia
|
May 26, 2016
Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML
H Wu, A Wang, Z Qi, et al.
Oncotarget
|
April 16, 2016
Characterization of selective and potent PI3Kδ inhibitor (PI3KDIN- 015) for B-Cell malignances
Xiaochuan Liu, Aoli Wang, Xiaofei Liang, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Phosphorylation-inducing chimera rewires oncogenic kinase to trigger apoptosis
Manuel L Merz, Veronika M Shoba, Rajaiah Pergu, et al.
Nature Chemical Biology
|
October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3
Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
ACS Central Science
|
April 27, 2026
Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis
Manuel L Merz, Veronika M Shoba, Rajaiah Pergu, et al.
Scientific Reports
|
March 27, 2020
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Nathan J Schauer, Xiaoxi Liu, Robert S Magin, et al.
Leukemia
|
July 14, 2015
Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
H Wu, C Hu, A Wang, et al.
Leukemia
|
May 6, 2026
Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
H Wu, C Hu, A Wang, et al.
Page
of 8